Chemoradiation for patients with advanced oral cavity cancer

Laryngoscope

Volumn 120, Issue 1, 2010, Pages 93-99

  Stenson, Kerstin M ^a   Kunnavakkam, Rangesh ^a   Cohen, Ezra E W ^a   Portugal, Louis D ^a   Blair, Elizabeth ^a   Haraf, Daniel J ^a   Salama, Joseph ^a   Vokes, Everett E ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; FLUOROURACIL; HYDROXYUREA; PACLITAXEL;

ADULT; ADVANCED CANCER; ARTICLE; BONE NECROSIS; CANCER SURGERY; CANCER SURVIVAL; FEMALE; GLOSSECTOMY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SWALLOWING; TONGUE CANCER; TREATMENT OUTCOME; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FOLLOW UP; MIDDLE AGED; MORTALITY; MOUTH TUMOR; PHYSIOLOGY; TONGUE TUMOR;

COMBINED MODALITY THERAPY; DEGLUTITION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; OSTEORADIONECROSIS; TONGUE NEOPLASMS;

EID: 74049159599     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.20716     Document Type: Article

References (22)

1. Brizel DM, Esclamado R. Concurrent chemoradiotherapy for locally advanced, nonmetastatic, squamous carcinoma of the head and neck: consensus, controversy, and conundrum. J Clin Oncol 2006;24:2612-2617.
2. Kock WM, Lee DJ, Eisele DW, et al. Chemoradiotherapy for organ preservation in oral and pharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 1995;121:974-980.
3. Lavertu P, Adelstein DJ, Saxton JP, et al. Aggressive concurrent chemoradiotherapy for squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg 1999;125: 142-148.
4. Robbins KT, Kumar P, Wong FS, et al. Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients. Head Neck 2000;22:687-693.
5. Hanna E, Alexiou M, Morgan J, et al. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck. Arch Otolaryngol Head Neck Surg 2004;130:861-867.
6. Adelstein DJ, Saxton JP, Rybicki LA, et al. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution. J Clin Oncol 2006;24:1064-1071.
7. Posner MR, Hershock DM, Blajman CR, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007;357:1705-1715.
8. Curran D, Giralt J, Harari PM, et al. Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab. J Clin Oncol 2007;25:2191-2197.
9. El-Deiry M, Funk GF, Nalwa S, et al. Long-term quality of life for surgical and nonsurgical treatment of head and neck cancer. Arch Otolaryngol Head Neck Surg 2005;131: 879-885.
10. Samant S, Robbins KT, Kumar P, Ma JZ, Vieira F, Hanchett C. Bone or cartilage invasion by advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2001;127: 1451-1456.
11. Choi KK, Kim MJ, Yun PY, et al. Independent prognostic factors of 861 cases of oral squamous cell carcinoma in Korean adults. Oral Oncol 2006;42:208-217.
12. Klug C, Wutzl A, Kermer C, et al. Preoperative radiochemotherapy and radical resection for stages II-IV oral and oropharyngeal cancer: outcome of 222 patients. Int J Oral Maxillofac Surg 2005;34:143-148.
13. Schuller DE, Ozer E, Agrawal A, Grecula JC, Rhoades CA, Young DC. Multimodal intensification regimens for advanced, resectable, previously untreated squamous cell cancer of the oral cavity, oropharynx, or hypopharynx. Arch Otolaryngol Head Neck Surg 2007;133:320-326.
14. Liao CT, Chang JT, Wang HM, et al. Surgical outcome of T4a and resected T4b oral cavity cancer. Cancer 2006; 107:337-344.
15. Giralt JL, Gonzalez J, del Campo JM, et al. Preoperative induction chemotherapy followed by concurrent chemoradiotherapy in advanced carcinoma of the oral cavity and oropharynx. Cancer 2000;89:939-945.
16. Fuwa N, Kodaira T, Furutani K, et al. Intra-arterial chemoradiotherapy for locally advanced oral cavity cancer: analysis of therapeutic results in 134 cases. Br J Cancer 2008;98:1039-1045.
17. Machtay M, Moughan J, Trotti A, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer. J Clin Oncol 2008;26:3582-3589.
18. Turner SL, Slevin NJ, Gupta NK, Swindell R. Radical external beam radiotherapy for 333 squamous carcinomas of the oral cavity-evaluation of the late morbidity and a watch policy for the clinically negative neck. Radiother Oncol 1996;41:21-29.
19. Reuther T, Schuster T, Mende U, Kubler A. Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients-a report of a thirty year retrospective review. Int J Oral Maxillofac Surg 2003;32: 289-295.
20. Jererczek-Fossa BA, Orecchia R. Radiotherapy-induced mandibular bone complications. Cancer Treat Rev 2002; 28:65-74.
21. Costantino PD, Friedman CD, Steinberg MJ. Irradiated bone and its management. Otolaryngol Clin North Am 1995;28:1021-1037.
22. Sciubba JJ, Goldenberg D. Oral complications of radiotherapy. Lancet Oncol 2006;7:175-183.